ITTO20050691A1 - Uso di neboglamine nella terapia delle tossicodipendenze - Google Patents

Uso di neboglamine nella terapia delle tossicodipendenze

Info

Publication number: ITTO20050691A1
Authority: IT; Italy
Prior art keywords: neboglamins; drug treatment; treatment therapy; toxicodependency; mescalin
Prior art date: 2005-10-04

Application number

IT000691A

Other languages

English (en)

Inventor

Gianfranco Caselli

Antonio Giordani

Francesco Makovec

Lucio Claudio Rovati

Original Assignee

Rottapharm Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-10-04

Filing date

2005-10-04

Publication date

2007-04-05

2005-10-04 Application filed by Rottapharm Spa filed Critical Rottapharm Spa

2005-10-04 Priority to IT000691A priority Critical patent/ITTO20050691A1/it

2006-10-03 Priority to ES06809478T priority patent/ES2323982T3/es

2006-10-03 Priority to PCT/IB2006/053603 priority patent/WO2007039869A2/en

2006-10-03 Priority to AU2006298393A priority patent/AU2006298393B2/en

2006-10-03 Priority to DE602006005831T priority patent/DE602006005831D1/de

2006-10-03 Priority to US12/067,390 priority patent/US20100197962A1/en

2006-10-03 Priority to AT06809478T priority patent/ATE425748T1/de

2006-10-03 Priority to EP06809478A priority patent/EP1940376B1/en

2006-10-03 Priority to JP2008534130A priority patent/JP2009510158A/ja

2006-10-03 Priority to CA2624449A priority patent/CA2624449C/en

2007-04-05 Publication of ITTO20050691A1 publication Critical patent/ITTO20050691A1/it

2011-07-27 Priority to US13/192,071 priority patent/US8258185B2/en

Links

239000003814 drug Substances 0.000 title abstract 3
229940079593 drug Drugs 0.000 title abstract 2
238000002560 therapeutic procedure Methods 0.000 title 1
VCRGLZYPNNAVRP-JTQLQIEISA-N (4s)-4-amino-5-[(4,4-dimethylcyclohexyl)amino]-5-oxopentanoic acid Chemical compound CC1(C)CCC(NC(=O)[C@@H](N)CCC(O)=O)CC1 VCRGLZYPNNAVRP-JTQLQIEISA-N 0.000 abstract 3
ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 abstract 2
240000004308 marijuana Species 0.000 abstract 2
235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 abstract 1
235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 abstract 1
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 abstract 1
229940125717 barbiturate Drugs 0.000 abstract 1
229940049706 benzodiazepine Drugs 0.000 abstract 1
150000001557 benzodiazepines Chemical class 0.000 abstract 1
229960003920 cocaine Drugs 0.000 abstract 1
235000013922 glutamic acid Nutrition 0.000 abstract 1
239000004220 glutamic acid Substances 0.000 abstract 1
239000000380 hallucinogen Substances 0.000 abstract 1
RHCSKNNOAZULRK-UHFFFAOYSA-N mescaline Chemical compound COC1=CC(CCN)=CC(OC)=C1OC RHCSKNNOAZULRK-UHFFFAOYSA-N 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
229950007573 neboglamine Drugs 0.000 abstract 1
229940127240 opiate Drugs 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
229940125723 sedative agent Drugs 0.000 abstract 1
239000000932 sedative agent Substances 0.000 abstract 1
239000000021 stimulant Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Addiction (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Neurology (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Psychiatry (AREA)
Epidemiology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Saccharide Compounds (AREA)

IT000691A 2005-10-04 2005-10-04 Uso di neboglamine nella terapia delle tossicodipendenze ITTO20050691A1 (it)

Priority Applications (11)

Application Number	Priority Date	Filing Date	Title
IT000691A ITTO20050691A1 (it)	2005-10-04	2005-10-04	Uso di neboglamine nella terapia delle tossicodipendenze
US12/067,390 US20100197962A1 (en)	2005-10-04	2006-10-03	Use of Neboglamine in the Treatment of Toxicodependency
PCT/IB2006/053603 WO2007039869A2 (en)	2005-10-04	2006-10-03	Use of neboglamine in the treatment of toxicodependency
AU2006298393A AU2006298393B2 (en)	2005-10-04	2006-10-03	Use of neboglamine in the treatment of toxicodependency
DE602006005831T DE602006005831D1 (de)	2005-10-04	2006-10-03	Verwendung von neboglamin bei der behandlung von abhängigkeit von toxischen substanzen
ES06809478T ES2323982T3 (es)	2005-10-04	2006-10-03	Uso de neboglamina en el tratamiento de la toxicodependencia.
AT06809478T ATE425748T1 (de)	2005-10-04	2006-10-03	Verwendung von neboglamin bei der behandlung von abhangigkeit von toxischen substanzen
EP06809478A EP1940376B1 (en)	2005-10-04	2006-10-03	Use of neboglamine in the treatment of toxicodependency
JP2008534130A JP2009510158A (ja)	2005-10-04	2006-10-03	毒物依存症の治療におけるネボグラミンの使用
CA2624449A CA2624449C (en)	2005-10-04	2006-10-03	Use of neboglamine in the treatment of toxicodependency
US13/192,071 US8258185B2 (en)	2005-10-04	2011-07-27	Use of neboglamine in the treatment of toxicodependency

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IT000691A ITTO20050691A1 (it)	2005-10-04	2005-10-04	Uso di neboglamine nella terapia delle tossicodipendenze

Publications (1)

Publication Number	Publication Date
ITTO20050691A1 true ITTO20050691A1 (it)	2007-04-05

Family

ID=37814217

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IT000691A ITTO20050691A1 (it)	2005-10-04	2005-10-04	Uso di neboglamine nella terapia delle tossicodipendenze

Country Status (10)

Country	Link
US (2)	US20100197962A1 (it)
EP (1)	EP1940376B1 (it)
JP (1)	JP2009510158A (it)
AT (1)	ATE425748T1 (it)
AU (1)	AU2006298393B2 (it)
CA (1)	CA2624449C (it)
DE (1)	DE602006005831D1 (it)
ES (1)	ES2323982T3 (it)
IT (1)	ITTO20050691A1 (it)
WO (1)	WO2007039869A2 (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US12458906B2 (en)	2018-01-23	2025-11-04	High Sierra Technologies, Inc.	Methods of modifying a naturally occurring cannabis raw plant material, a purified cannabis product from a naturally occurring cannabis raw plant material, and a modified cannabis product from a naturally occurring cannabis raw plant material
EP3743055B1 (en)	2018-01-23	2024-03-06	High Sierra Technologies, Inc.	Cannabis products modified by removing volatile organic compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9024738D0 (en) *	1990-11-14	1991-01-02	Erba Carlo Spa	A new method of treatment of tumor necroisis factor(tnf)-related diseases
GB9109007D0 (en) *	1991-04-26	1991-06-12	Merck Sharp & Dohme	Therapeutic method
IT1264765B1 (it) *	1993-03-10	1996-10-04	Rotta Research Lab	Derivati dell'acido glutammico ed acido aspartico, procedimento per la loro preparazione e loro uso come farmaci potenzianti la
US5523323A (en) *	1993-09-14	1996-06-04	Maccecchini; Maria-Luisa	Use of partial agonists of the NMDA receptor to reduce opiate induced tolerance and dependence
ITTO20040343A1 (it) *	2004-05-24	2004-08-24	Rotta Res Lab Spa	Uso di neboglamine (cr2249) come neuropsicotico e neuroprotettivo

2005
- 2005-10-04 IT IT000691A patent/ITTO20050691A1/it unknown
2006
- 2006-10-03 JP JP2008534130A patent/JP2009510158A/ja active Pending
- 2006-10-03 EP EP06809478A patent/EP1940376B1/en not_active Not-in-force
- 2006-10-03 DE DE602006005831T patent/DE602006005831D1/de active Active
- 2006-10-03 CA CA2624449A patent/CA2624449C/en not_active Expired - Fee Related
- 2006-10-03 ES ES06809478T patent/ES2323982T3/es active Active
- 2006-10-03 US US12/067,390 patent/US20100197962A1/en not_active Abandoned
- 2006-10-03 AU AU2006298393A patent/AU2006298393B2/en not_active Ceased
- 2006-10-03 AT AT06809478T patent/ATE425748T1/de not_active IP Right Cessation
- 2006-10-03 WO PCT/IB2006/053603 patent/WO2007039869A2/en not_active Ceased
2011
- 2011-07-27 US US13/192,071 patent/US8258185B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US20110288173A1 (en)	2011-11-24
CA2624449C (en)	2013-12-17
JP2009510158A (ja)	2009-03-12
EP1940376A2 (en)	2008-07-09
DE602006005831D1 (de)	2009-04-30
WO2007039869A3 (en)	2007-07-05
US8258185B2 (en)	2012-09-04
WO2007039869A2 (en)	2007-04-12
EP1940376B1 (en)	2009-03-18
AU2006298393B2 (en)	2011-04-14
AU2006298393A1 (en)	2007-04-12
ATE425748T1 (de)	2009-04-15
US20100197962A1 (en)	2010-08-05
ES2323982T3 (es)	2009-07-28
CA2624449A1 (en)	2007-04-12

Similar Documents

Publication	Publication Date	Title
WO2006033006A3 (en)	2006-07-06	Therapeutic combinations comprising poly(adp-ribose) polymerases inhibitor
BRPI0416628A (pt)	2007-01-16	uso de compostos orgánicos
DE602004029580D1 (de)	2010-11-25	Substituierte indolderivate für eine pharmazeutische zusammensetzung zur behandlung von atemwegserkrankungen
BR0207883A (pt)	2004-07-27	Composições de medicamentos à base de anticolenérgicos e inibidores de pde-iv
BRPI0407662A (pt)	2006-03-01	derivados do ácido 1-fenilalcanocarboxìlico para o tratamento de doenças neurodegenerativas
WO2006116148A3 (en)	2008-09-12	(7-arlysubstituted 2, 3-dihydr0-1-benz0furan-2-yl) alkylamines in the treatment' of substance abuse
UY27759A1 (es)	2003-11-28	Combinaciones de medicamentos que contienen compuestos heterocíclicos y un nuevo agente anticolinérgico.
MY145647A (en)	2012-03-15	(4-hydroxy-2-oxo-3h-benzothiazol-7-yl)ethylamine derivatives, processes for their preparation, pharmaceutical compositions containing them and their use in therapy (for example in the treatment of respiratory disease states)
AR035889A1 (es)	2004-07-21	Citrato de 5,7,14-triazatetraciclo[10.3.1.02,11.04,9]hexadeca-2(11),3,5,7,9- pentaeno y composiciones farmaceuticas que la contienen y su uso para la elaboracion de medicamentos
WO2004105773A3 (en)	2006-04-27	Use of s1p
NO20073176L (no)	2007-09-17	Nye medikamenter for behandling av luftveissykdommer
CL2004001068A1 (es)	2005-04-15	Compuestos derivados de 2,3,4,5-tetrahidrobenzo[f][1,4]oxazepina; procedimientos de preparacion; composicion farmaceutica que los contiene y su uso en la elaboracion de un medicamento util para el tratamiento de la enfermedad de alzheimer.
IL187575A (en)	2012-12-31	Benzofuranyl derivatives ,pharmaceutical formulations comprising the same and use thereof in the preparation of medicaments for the treatment of 5-ht6-receptor related disorders
EA200900269A1 (ru)	2009-08-28	Лекарственные комбинации для лечения заболеваний дыхательных путей
WO2008004100A9 (en)	2012-04-19	Therapeutic compounds
ITTO20050691A1 (it)	2007-04-05	Uso di neboglamine nella terapia delle tossicodipendenze
BR0312507A (pt)	2005-04-12	Composições de medicamentos à base de novos anticolinérgicos e inibidores de egfr-cinase
BRPI0413101A (pt)	2006-10-03	compostos de sulfonamida derivado de benzoxazinona, sua preparação e uso como medicamentos
BRPI0409170A (pt)	2006-04-11	combinações compreendendo drogas antiepilépticas para o tratamento de distúrbios neurológicos
WO2008120617A1 (ja)	2008-10-09	クローン病に伴う腸管狭窄の進展抑制用医薬組成物
WO2007026254A3 (en)	2007-07-05	Benzodiazepine derivatives , their preparation and the therapeutic use thereof
DE602005017629D1 (de)	2009-12-24	Pharmazeutische zusammensetzungen zur behandlung von leishmaniasis
ITTO20040343A1 (it)	2004-08-24	Uso di neboglamine (cr2249) come neuropsicotico e neuroprotettivo
DE602004020337D1 (de)	2009-05-14	Anticholinergika enthaltende Arzneimittel zur Behandlung von Krankheiten der ableitenden Harnwege
WO2006117624A3 (en)	2007-03-01	Kynurenic acid and salts thereof for the prevention and treatment of shock